Acetonitrile - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The acetonitrile market size is expected to increase from USD 480.17 million in 2025 to USD 510.22 million in 2026 and reach USD 670.32 million by 2031, at a CAGR of 5.61% over 2026-2031. This report is Segmented by Grade (Industrial Grade, Electronic Grade, and More), Purity Level (Anhydrous, Standard Purity, and More), Application (Solvent, Reagent, and More), End-User Industry (Pharmaceuticals, Chemical Manufacturing, and More), and Geography (Asia-Pacific, North America, Europe, South America, and Middle-East and Africa). The Market Forecasts are Provided in Terms of Value (USD).

Global Acetonitrile Market Trends and Insights

Growing Demand for High-Purity Acetonitrile in Pharmaceutical Manufacturing and Drug Synthesis

Pharmaceutical manufacturing demand for acetonitrile is expanding beyond established high-performance liquid chromatography (HPLC) and active pharmaceutical ingredient applications. Solid-phase oligonucleotide synthesis, including work on glucagon-like peptide-1 (GLP-1) receptor agonists and antisense therapies, requires large volumes of high-purity solvent. Acetonitrile use per kilogram of output is higher in these workflows than in many conventional small-molecule processes. SK Pharmteco, Ionis Pharmaceuticals, and GEA have assessed industrial recovery and reuse methods for acetonitrile from oligonucleotide synthesis streams, indicating that supply availability has become a manufacturing concern for drug producers. Contract development and manufacturing organizations also require consistent grades, traceability, and complete current Good Manufacturing Practice (cGMP) documentation. FDA and European Medicines Agency requirements for solvent residues reinforce demand for pharmaceutical and HPLC grades that meet regulated specifications.

Increasing Adoption of Acetonitrile in HPLC and Analytical Laboratory Applications

The acetonitrile market benefits from its established role in HPLC and liquid chromatography-mass spectrometry (LC-MS) testing. Its ultraviolet transparency, low viscosity, and compatibility with water make it suitable as a mobile phase in pharmaceutical and bioanalytical methods. The shift toward ultra-high-performance liquid chromatography (UHPLC) increases solvent use per analysis cycle, as these instruments operate at higher pressure with smaller-particle columns. Regulated laboratories must use high-purity material that performs consistently across validated methods. This requirement limits spot purchasing and favors suppliers that have completed qualification processes. The growing number of pharmaceutical quality-control laboratories in India and South Korea is driving demand for analytical-grade acetonitrile.

Stringent Health, Safety, and Environmental Regulations for Acetonitrile Handling and Storage

European Union rules classify acetonitrile as a Category 2 flammable liquid and identify acute oral, dermal, and inhalation hazards. These requirements increase costs for storage, worker protection, handling equipment, and waste disposal. Smaller laboratories face higher costs when they lack access to centralized solvent recovery systems. The burden differs by region, as many North American and European pharmaceutical facilities already operate established recovery and compliance programs. New suppliers must provide chemical documentation and evidence of hazardous-substance compliance before qualification, which can lengthen lead times and increase reliance on approved suppliers.

Other drivers and restraints analyzed in the detailed report include:

• Rising Use of Acetonitrile in Agrochemical Production and Chemical Extraction Processes
• Expanding Demand from the Electronics and Semiconductor Industries for High-Purity Solvents
• Supply Constraints Due to Dependence on Acrylonitrile Production

Segment Analysis

Industrial grade held 46.52% of the acetonitrile market share in 2025. It serves chemical synthesis, agrochemical extraction, and electrochemical processes where cost and reliable availability are important. This grade remains the foundation of the acetonitrile market, as many industrial applications do not require the lowest possible impurity levels. Its broad application base supports demand across chemical-processing regions. However, industrial-grade material competes directly with standard-grade supplies from Asian producers, which can constrain margins when buyers do not require specialized documentation. Industrial suppliers must therefore balance sales volume with investments that improve operational efficiency. This grade continues to account for a large share of physical demand in the acetonitrile market.

Electronic grade is forecast to grow at a 6.47% CAGR from 2026 to 2031. This grade addresses semiconductor applications that require metallic impurities below 1 ppb, a specification that standard industrial material cannot meet without dedicated purification and quality-control systems. MilliporeSigma lists electronic-grade acetonitrile at 99.999% trace-metals purity for battery applications. Certified quality records and application-specific assurance support higher realized prices for this material. Producers with electronic-grade capacity can serve a smaller but more demanding customer group. The acetonitrile market is thus separating into high-volume industrial supply and higher-value specialty supply, a distinction that affects capacity allocation, customer qualification, and pricing.

High-purity acetonitrile, with a purity of at least 99.9%, held 44.61% of the purity-level segment in 2025. It is widely used by pharmaceutical manufacturers and analytical laboratories that require dependable and repeatable performance. This leading position reflects the large contribution of regulated applications to the acetonitrile market. Standard and other purity levels remain important for extraction and industrial synthesis, where buyers are more price-sensitive and sub-ppm specifications are not always required. This creates a different competitive environment for suppliers serving standard-grade demand. High-purity material, therefore, remains central to revenue quality in the acetonitrile market.

Anhydrous acetonitrile is projected to grow at a 6.22% CAGR through 2031. Oligonucleotide drug synthesis requires tight control of water content, as moisture can reduce coupling efficiency and yield, making anhydrous material difficult to replace in these workflows. While standard-purity acetonitrile competes with alternative solvents in certain industrial uses, anhydrous acetonitrile has fewer practical substitutes in this therapeutic manufacturing process. Pharmaceutical customers also require compliance with residual solvent guidelines under ICH Q3C, which favors suppliers able to demonstrate purity, consistency, and documented handling. The acetonitrile market for anhydrous material is therefore tied to the expansion of advanced drug manufacturing, as well as to producers maintaining sufficient purification and logistics capacity.

Complete Report Scope:

• By Grade
  • Industrial Grade
  • Electronic Grade
  • Pharmaceutical Grade
  • Analytical/Reagent Grade
• By Purity Level
  • High Purity (greater than or equal to 99.9%)
  • Anhydrous
  • Standard Purity
  • Other Purity Levels
• By Application
  • Solvent
  • Reagent
  • Extraction
  • Chromatography
  • Electrochemistry
• By End-User Industry
  • Pharmaceuticals
  • Chemical Manufacturing
  • Agrochemicals
  • Electronics and Semiconductors
  • Biotechnology
  • Analytical Laboratories and Research Institutes
  • Other End-User Industries
• By Geography
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Russia
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle-East and Africa
    • Saudi Arabia
    • South Africa
    • Rest of Middle-East and Africa

Geography Analysis

Asia-Pacific held 43.55% of the acetonitrile market share in 2025 and is forecast to grow at a 6.04% CAGR through 2031. China has significant upstream production capacity, while India, China, and South Korea support large pharmaceutical active ingredient manufacturing bases. Chinese producers influence commodity-grade pricing throughout the region. India is becoming a key demand center as pharmaceutical and active pharmaceutical ingredient (API) production expands. Japan and South Korea generate high-value demand through semiconductor fabrication and advanced battery manufacturing. Asahi Kasei's electrolyte technology licensing positions Japan as the origin of a new acetonitrile application. The regional market benefits from rising investment in biotechnology research and manufacturing. Supply qualification remains important because electronics and pharmaceutical customers require different grades and documentation.

North America is the second-largest regional market. The United States supports demand through pharmaceutical manufacturing, laboratory infrastructure, and local nitrile production. Ascend Performance Materials opened a high-purity acetonitrile recovery and purification facility at Chocolate Bayou in Alvin, Texas, on February 4, 2026. The site recovers co-produced material and refines it to pharmaceutical and analytical specifications. This development has improved regional supply resilience and reduced dependence on imported specialty-grade material. Europe remains a regulated premium market where REACH and Classification, Labeling and Packaging (CLP) obligations create a compliance threshold for suppliers. INEOS Nitriles is Europe's sole producer and serves a market that places strong value on qualified supply.

South America, the Middle-East, and Africa remain early-stage demand regions for the acetonitrile market. Brazil and Argentina support demand through generic drug and crop-protection manufacturing. South Africa's pharmaceutical and mining chemical sectors account for much of the regional demand. Saudi Arabia is expanding specialty chemical capacity and has pharmaceutical localization goals. Both regions rely substantially on imports for ultra-high-purity grades, creating an opening for suppliers that can provide distribution, documentation, technical support, and dependable inventory. Near-term demand is smaller but can become recurring as pharmaceutical and industrial sites reach operating scale. Reliance on imports lengthens lead times for laboratories and manufacturers requiring validated high-purity materials and increases the importance of local warehousing and technical support. Regional entry requires more than product availability, as buyers need quality records and support for safe handling. Generic drug production can raise demand for pharmaceutical and analytical grades over time, while crop-protection manufacturing supports a separate base of standard and extraction-grade demand. The supply gap is most visible for ultra-high-purity material used in laboratory and electronics applications.

List of Companies Covered in this Report:

• Alkyl Amines Chemicals Limited
• Alzchem Group AG
• Asahi Kasei Corporation
• Avantor, Inc.
• Concord Technology (Tianjin) Co., Ltd.
• Henan GP Chemicals Co., Ltd
• Imperial Chemical Corporation
• INEOS
• Nova Molecular Technologies
• TAEKWANG INDUSTRIAL CO., LTD.
• Tedia Company, LLC.
• Thermo Fisher Scientific Inc.
• Vizag Chemical

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support